The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...
Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...
Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.
Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...
Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSEâ„¢ Platform for the treatment of drug ...
Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...
LEMO announces an advancement in its REDEL 2P High Voltage Series with the introduction of new connectors featuring 26 and 34 ...
Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its ...
Dr. Mehran Attari, a cardiac electrophysiologist with Mercy Health, discusses a new treatment option for atrial fibrillation (AFib): pulse field ablation (PFA). Atrial fibrillation is the most common ...